234 related articles for article (PubMed ID: 31919146)
1. Individual and county-level variation in outcomes following non-fatal opioid-involved overdose.
Lowder EM; Amlung J; Ray BR
J Epidemiol Community Health; 2020 Apr; 74(4):369-376. PubMed ID: 31919146
[TBL] [Abstract][Full Text] [Related]
2. EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana.
Ray BR; Lowder EM; Kivisto AJ; Phalen P; Gil H
Addiction; 2018 Dec; 113(12):2271-2279. PubMed ID: 30255531
[TBL] [Abstract][Full Text] [Related]
3. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
Kelty E; Hulse G
Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
[TBL] [Abstract][Full Text] [Related]
4. Racial Inequality in Receipt of Medications for Opioid Use Disorder.
Barnett ML; Meara E; Lewinson T; Hardy B; Chyn D; Onsando M; Huskamp HA; Mehrotra A; Morden NE
N Engl J Med; 2023 May; 388(19):1779-1789. PubMed ID: 37163624
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
6. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
[TBL] [Abstract][Full Text] [Related]
7. Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases.
Sugarman OK; Saloner B; Richards TM; Lasser EC; Heath T; Idries S; Weiner JP; Bandara S
Drug Alcohol Depend; 2024 May; 258():111281. PubMed ID: 38599134
[TBL] [Abstract][Full Text] [Related]
8. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
[TBL] [Abstract][Full Text] [Related]
9. Opioid-dependent error processing.
Fellows-Smith J
J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
[TBL] [Abstract][Full Text] [Related]
10. Comparison between buprenorphine provider availability and opioid deaths among US counties.
Jones CW; Christman Z; Smith CM; Safferman MR; Salzman M; Baston K; Haroz R
J Subst Abuse Treat; 2018 Oct; 93():19-25. PubMed ID: 30126537
[TBL] [Abstract][Full Text] [Related]
11. Patient-Level and County-Level Trends in Nonfatal Opioid-Involved Overdose Emergency Medical Services Encounters - 491 Counties, United States, January 2018-March 2022.
Casillas SM; Pickens CM; Stokes EK; Walters J; Vivolo-Kantor A
MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(34):1073-1080. PubMed ID: 36006833
[TBL] [Abstract][Full Text] [Related]
12. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Larochelle MR; Bernson D; Land T; Stopka TJ; Wang N; Xuan Z; Bagley SM; Liebschutz JM; Walley AY
Ann Intern Med; 2018 Aug; 169(3):137-145. PubMed ID: 29913516
[TBL] [Abstract][Full Text] [Related]
13. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
14. Opportunities for Emergency Medical Services Intervention to Prevent Opioid Overdose Mortality.
Barefoot EH; Cyr JM; Brice JH; Bachman MW; Williams JG; Cabanas JG; Herbert KM
Prehosp Emerg Care; 2021; 25(2):182-190. PubMed ID: 32176548
[TBL] [Abstract][Full Text] [Related]
15. Disparities in opioid overdose survival and naloxone administration in Pennsylvania.
Holmes LM; Rishworth A; King BH
Drug Alcohol Depend; 2022 Sep; 238():109555. PubMed ID: 35810621
[TBL] [Abstract][Full Text] [Related]
16. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
[TBL] [Abstract][Full Text] [Related]
17. Overdose and mortality risk following a non-fatal opioid overdose treated by Emergency Medical Services in King County, Washington.
Hood JE; Aleshin-Guendel S; Poel A; Liu J; Collins HN; Sadinle M; Avoundjian T; Sayre MR; Rea TD
Drug Alcohol Depend; 2023 Dec; 253():111009. PubMed ID: 37984033
[TBL] [Abstract][Full Text] [Related]
18. County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities.
Rizk JG; Saini J; Kim K; Pathan U; Qato DM
PLoS One; 2024; 19(4):e0301863. PubMed ID: 38578818
[TBL] [Abstract][Full Text] [Related]
19. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
[TBL] [Abstract][Full Text] [Related]
20. Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality.
Lei F; Lofwall MR; McAninch J; Adatorwovor R; Slade E; Freeman PR; Moga DC; Dasgupta N; Walsh SL; Vickers-Smith R; Slavova S
J Addict Med; 2024 May-Jun 01; 18(3):319-326. PubMed ID: 38598300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
